Social tensions at the European Patent Office seem to have reached new lows in a meeting last week between an 'extremely hostile' EPO president Antonio Campinos and staff representatives.
In a…
Having been teaching Public International Law since 1990 and being a tenured professor of this field of law, this author has some difficulty in understanding the state of collective nirvana that the…
The hurdle for being a co-inventor in a medicine field in Japan might be a little higher than what is expected from precedents. The IP High Court affirmed, in its judgement of 17th March 2021 (2020 (…
Another constitutional complaint against the Unified Patent Court Agreement? Is Italy withdrawing from the UPC? If even April fools’ day doesn’t go by without a proportion of jokes on the Unitary…
The European Patent Office (EPO) received 188 600 applications in 2021, up 4.5% on the previous year and the highest number to date, according to the EPO's Patent Index 2021. Patent filings rebounded…
The trade union SUEPO has claimed the strike it called for during the meeting of the Administrative Council on 22 March 2022 was a ‘striking success’.
According to a statement it sent to its members…
In two separate judgments, the Full Court has provided much needed clarity on how to identify the pharmaceutical products that can support a valid patent term extension in Australia, as Natalie…
In a complex case concerning blockbuster cinacalcet, Section 15 of the Barcelona Court of Appeals makes findings on the non-obviousness of inventions consisting of the provision of an unexpected…
Since 19 January 2022, the provisional application protocol (“PAP”) of the UPCA has officially entered into force. However, as previously reported, this entry into force of UPC faces a number of…
SPCs are often valuable and therefore important to their proprietors. Indeed, such is the potential value of an additional period of exclusivity, that in the last decade or so, we have seen SPCs…
